Logo

EMBL and Abnova Team Up to Produce Monoclonal Antibodies in High Throughput

Nov 09, 2004

NEW YORK, Nov. 9 (GenomeWeb News) - The European Molecular Biology Laboratory and Abnova of Taiwan will join forces to produce monoclonal antibodies in high throughput, the two partners said today.

 

EMBL will contribute technologies relating to automation and monoclonal antibody production developed at its Monoclonal Core Facility in Monterotondo, Italy, to enhance Abnova's facilities in Taiwan.

 

EMBL Enterprise Management and Abnova also plan to collaborate in marketing a custom OEM monoclonal antibody service. Abnova has formed a subsidiary in Germany to expand the custom service for academic and industrial researchers.

 

Abnova said it is currently developing an antibody catalog for drug discovery and diagnostics, focusing on antibodies against human kinases, receptors, apoptosis proteins, stem cell proteins, and plasma proteins.

Breaking News
The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.